ArticleCancers2024

Tripartite Motif-Containing 2, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Triple-Negative Breast Cancer Treated with Chemotherapy.

Brendah K Masisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.